Literature DB >> 18685038

Developmental neuronal death in hippocampus requires the microglial CD11b integrin and DAP12 immunoreceptor.

Shirley Wakselman1, Catherine Béchade, Anne Roumier, Delphine Bernard, Antoine Triller, Alain Bessis.   

Abstract

In several brain regions, microglia actively promote neuronal apoptosis during development. However, molecular actors leading microglia to trigger death remain mostly unknown. Here, we show that, in the developing hippocampus, apoptotic neurons are contacted by microglia expressing both the integrin CD11b and the immunoreceptor DAP12. We demonstrate that developmental apoptosis decreases in mice deficient for CD11b or DAP12. In addition, function-blocking antibodies directed against CD11b decrease neuronal death when injected into wild-type neonates, but have no effect when injected into DAP12-deficient littermates. This demonstrates that DAP12 and CD11b act in converging pathways to induce neuronal death. Finally, we show that DAP12 and CD11b control the production of microglial superoxide ions, which kill the neurons. Thus, our data show that the process of developmental neuronal death triggered by microglia is similar to the elimination of pathogenic cells by the innate immune cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18685038      PMCID: PMC6670768          DOI: 10.1523/JNEUROSCI.1006-08.2008

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  140 in total

1.  Sialic acid on the neuronal glycocalyx prevents complement C1 binding and complement receptor-3-mediated removal by microglia.

Authors:  Bettina Linnartz; Jens Kopatz; Andrea J Tenner; Harald Neumann
Journal:  J Neurosci       Date:  2012-01-18       Impact factor: 6.167

2.  Neuron-Microglia Dialogue and Hippocampal Neurogenesis in the Aged Brain.

Authors:  Carmelina Gemma; Adam D Bachstetter; Paula C Bickford
Journal:  Aging Dis       Date:  2010-12-01       Impact factor: 6.745

Review 3.  The myeloid cells of the central nervous system parenchyma.

Authors:  Richard M Ransohoff; Astrid E Cardona
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

Review 4.  Microglia antioxidant systems and redox signalling.

Authors:  F Vilhardt; J Haslund-Vinding; V Jaquet; G McBean
Journal:  Br J Pharmacol       Date:  2016-03-03       Impact factor: 8.739

Review 5.  Microglial interactions with the neurovascular system in physiology and pathology.

Authors:  Xiaoliang Zhao; Ukpong B Eyo; Madhuvika Murugan; Long-Jun Wu
Journal:  Dev Neurobiol       Date:  2018-02-01       Impact factor: 3.964

Review 6.  Impact of prenatal immune system disturbances on brain development.

Authors:  Amrita Madhusudan; Prisca Vogel; Irene Knuesel
Journal:  J Neuroimmune Pharmacol       Date:  2012-05-13       Impact factor: 4.147

Review 7.  A decade of diverse microglial-neuronal physical interactions in the brain (2008-2018).

Authors:  Joseph O Uweru; Ukpong B Eyo
Journal:  Neurosci Lett       Date:  2019-01-06       Impact factor: 3.046

8.  Complement Targets Newborn Retinal Ganglion Cells for Phagocytic Elimination by Microglia.

Authors:  Sarah R Anderson; Jianmin Zhang; Michael R Steele; Cesar O Romero; Amanda G Kautzman; Dorothy P Schafer; Monica L Vetter
Journal:  J Neurosci       Date:  2019-01-15       Impact factor: 6.167

Review 9.  The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson's Disease.

Authors:  Phillip Mackie; Joe Lebowitz; Leila Saadatpour; Emily Nickoloff; Peter Gaskill; Habibeh Khoshbouei
Journal:  Brain Behav Immun       Date:  2018-03-15       Impact factor: 7.217

Review 10.  Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight.

Authors:  Yang Shi; David M Holtzman
Journal:  Nat Rev Immunol       Date:  2018-12       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.